Palliative care


THC BioMed Reports Growing Revenue & Profitability

April 22nd, 2020 - Ryan Allway

Cannabis investors had already been shifting from “unproven potential” to “profitability” over the past several quarters prior to the global health crisis. With the COVID-19 outbreak, investors have fled previous investments to profitable companies that aren’t reliant on costly or dilutive funding to sustain their operations. THC BioMed Intl Ltd. (CSE: THC) recently recorded its […]

Ehave, Inc. Appoints Dr. Mark Braunstein as Chief Psychedelic Officer

April 6th, 2020 - Ryan Allway

Dr. Braunstein is recognized worldwide in Psychedelic Psychiatry, which entails treating psychiatric disorders with psychedelics Dr. Braunstein is a renowned expert on psychedelic therapy and addiction. As a pioneer in psychedelic medicine research, he specializes in the treatment of ADHD, depression, anxiety, bipolar disorder, substance abuse, oppositional defiance, personality disorders, and treatment resistance. He has […]

Psychedelics: Investing in the Perfect BrainStorm

April 6th, 2020 - Ryan Allway

Psychedelics are rapidly becoming both a mainstream treatment option and investment opportunity. With growing interest among researchers, forward-thinking companies are starting to build a presence in the space.  In this article, we will take a look at the growing body of therapeutic evidence for psychedelics. How decriminalization is gaining ground, and how Ehave Inc. (OTC: […]

Cannabis Brands Want Their Own Store, CalEthos Deems it Essential

April 3rd, 2020 - Robin Lefferts

Cannabis Shelf Space Deemed Essential What is the ideal setting for a brand to showcase its wares to the retail consumer? It is certainly not a crowded store with hundreds of brands competing for limited shelf space and consumer attention. Every brand out there would much rather have its own store, featuring its own product […]

Psychedelics, the Next Frontier in Drug Research

March 1st, 2020 - Ryan Allway

A big factor in the recent rise of cannabis legalization is the emergence of legitimate scientific research into the potential health benefits of the plant’s active ingredients, called cannabinoids. Medicines are often derived from naturally occurring compounds, from aspirin to insulin to penicillin. A decent body of research is currently pointing to psilocybin, the psychedelic […]

Supreme Cannabis Announces Leadership Transition as Company Accelerates Transformation into Premium Cannabis CPG Company

January 6th, 2020 - Ryan Allway

Supreme Cannabis Board Director and former President of Starbucks Coffee Canada, Colin Moore, appointed Interim President and CEO. Navdeep Dhaliwal departs Company, effective immediately. Interim CEO to leverage successful track record to accelerate growth and transformation strategy, while improving speed to market and rightsizing operating and capital spends. Search for new CEO to begin immediately. […]

Canadian Cannabis Success Being Replayed in Israel Right Now, Featuring an Exclusive Isracann Biosciences CEO Video Interview Part #1

December 18th, 2019 - Ryan Allway

After experiencing success with the legalization of cannabis in Canada, Darryl Jones was looking for the next big cannabis opportunity. As it happens, that opportunity was 11,000 miles away from Vancouver in Israel. Fast forward and Jones is now President and CEO of Isracann Biosciences (CSE: IPOT) (OTCPK: ISCNF), Israel’s first pure-play cannabis company to […]

Supreme’s 7ACRES Continues to Impress

November 14th, 2019 - Ash Stringer

2018 was a stellar year for cannabis advocates as the green rush of marijuana legalization swept the globe, including California, the world’s fifth biggest economy, legalizing recreational marijuana and Canada becoming the first G20 nation to do so; however, 2019 may go down – surprisingly – as the year of a cannabis shake-out. Despite retreating […]

Snoop Dogg “Down With” Israeli Cannabis Company, Highlights Investment in the Country

October 30th, 2019 - Ash Stringer

Vocal cannabis activist Snoop Dogg has signed on as a brand ambassador for Israeli start-up Seedo (OTC: SEDO), the maker of a refrigerator-type of a machine for auto-growing plants, including cannabis. The indelible award-winning rapper says he’s “all the way down with” the Seedo Homelab and the utility it brings to allow people to grow […]

New Report: Women Prefer Cannabis Strains High in CBD

October 30th, 2019 - Ryan Allway

RYAH Finds Top Priority is Treating Mental Health, Over 28,000 Women Surveyed New York, NY, October 30, 2019 – RYAH Medtech, Inc. (“RYAH” or the “Company”), a big data and technology company focused on valuable predictive analysis in the global medical plant intake industry, has released a data analytics report on women and their medical […]

DNA Genetics Names Rakaa Taylor as Director of Marketing

October 15th, 2019 - Ryan Allway

Leading Global Cannabis Brand Selects Seasoned Marketing Manager, Brand Specialist, Creative Director and Hip Hop Veteran to Head Marketing Operations LOS ANGELES, Oct. 01, 2019 (GLOBE NEWSWIRE) — OG DNA Genetics (“DNA”, “DNA Genetics”, or the “Company”), a globally recognized leading cannabis brand, announced today that Rakaa Taylor will be joining the executive team as […]

CWCB Expo Los Angeles Connecting Cannabis Leaders & Investors

September 19th, 2019 - Ryan Allway

There are many difference cannabis industry conferences occurring every week in North America and around the world, but few are as iconic as the Cannabis World Congress & Business Exposition, which holds three events per year in New York, Los Angeles, and Boston. The upcoming Cannabis World Congress & Business Exposition (CWCB Expo) in Los […]

A Look Under the Rug at the Savvy Penetration of Europe’s Cannabis Market by Supreme Heights

September 6th, 2019 - Ryan Allway

As the nascent European legal cannabis market emerges, Canadian companies that have cut their teeth in their home markets are taking that experience overseas to capitalize on a much larger market opportunity. The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) is a model of how to build a successful cannabis portfolio at a blistering […]

Want a Powerplay Cannabis Brand? Know Your Consumer

September 6th, 2019 - Ash Stringer

With recreational or medical marijuana allowed in 33 U.S. states, about 224 million people now have legal access to cannabis. An April Hill-HarrisX poll showed that 84% of Americans now support legalizing marijuana, including 42% of respondents expressing their belief it should be legal for any use. The growing approval rates for cannabis signal a […]

Four Things to Look Forward to at Cannabis Science Conference West

September 4th, 2019 - Rachelle Gordon

The Cannabis Science Conference West officially begins tomorrow with a schedule jam-packed with inspiring and innovative speakers, dynamic presentations, a bustling expo floor – and of course, the parties. Thousands of industry entrepreneurs, experts, and enthusiasts are expected to turn out to the Portland Convention Center for two days of education, networking, and fellowship.  “We’re […]

FSD Pharma Brings in World-Renowned Experts to Build Bioscience Division

June 4th, 2019 - Ryan Allway

The cannabis industry is quickly maturing from home grows and bongs to industrial-scale cultivation and innovative new product formats. At the core of this transformation, science is helping transform medical cannabis into cutting-edge pharmaceuticals and recreational cannabis into compelling alternatives to tobacco and alcohol. Companies that recognize the role of science are best positioned to […]

How Celebrities & Politicians Help Build Cannabis Brands

May 31st, 2019 - Ryan Allway

There’s no doubt that celebrities can have a significant influence on a brand, particularly when it comes to Gen Z and Millennial demographics. At the same time, politicians can lend an air of credibility and provide valuable insights into the regulatory future of a market. These attributes have made them invaluable to cannabis companies that […]

Canntab Receives Cultivation Licence for Industrial Hemp

May 21st, 2019 - Ryan Allway

Enables Canntab to Leverage Properties in Saskatchewan and Ontario to Cultivate High Quality Hemp for the Extraction of Cannabidiol (CBD) Additionally, Canntab’s application is currently “In Progress” to obtain a Cannabis Licence (Processing- Standard, Federal Sales – Medical) from Health Canada at its Markham, Ontario facility. TORONTO, May 21, 2019 /CNW/ – Canntab Therapeutics Limited (CSE:PILL.CN) (OTCQX:CTABF) (FRA:TBF1.F) […]

Grown Rogue Talks Growth Strategy in Exclusive Interview

May 13th, 2019 - Ryan Allway

Multi-state operators, or MSOs, have become increasingly common across the United States given their economies of scale. With the industry’s relatively easy access to capital, many of these MSOs have bought up assets at all costs to rapidly build a footprint. Investors may want to avoid some of these companies and seek out those that […]

Pascal Biosciences Announces Formation of Clinical Advisory Board

May 8th, 2019 - Ryan Allway

Preeminent Neuro-Oncology Experts to Guide PAS-403 Development Efforts VANCOUVER, British Columbia and SEATTLE, May 08, 2019 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS)(“Pascal” or the “Company”), a drug discovery and development company, today announced it has formed a clinical advisory board (“CAB”) of preeminent neuro-oncology experts to guide its PAS-403 therapeutic program. PAS-403 is Pascal’s clinical […]

FSD Pharma Doubles Down on Endocannabinoid-based Pain Management

May 1st, 2019 - Ryan Allway

Chronic pain is a widespread condition affecting about one-third of the American population and billions of other people around the world. Despite their widely known dangers, opioids quickly became one of the most prescribed and profitable classes of drugs in the world. The ensuing opioid crisis has made overdoses a leading cause of non-disease deaths […]

Why Women, the Fastest Growing Consumers of Cannabis, are the Demographic to Watch

April 17th, 2019 - Joy Crosby

Although women control around $30 trillion in annual spending, the majority of companies often ignore this powerhouse of a demographic. Millennial women in particular tend to enjoy an above-average household income, and have been estimated to represent a $170 billion dollar market. Despite being a newer industry with a keen ability to identify exciting new […]


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading